Related Experiment Videos
Kappa opioid binding sites in rat spinal cord
J R Traynor1, M S Wood, J A Carroll
1Department of Chemistry, University of Technology, Loughborough, Leics, U.K.
NIDA Research Monograph
|January 1, 1986
Summary
Rat spinal cords have low levels of kappa-binding sites, similar to the brain. A novel binding site, unrelated to mu, delta, or kappa, was identified using [3H]Bremazocine.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Opioid receptors (mu, delta, kappa) are crucial in pain modulation.
- Understanding opioid receptor distribution in the rat spinal cord is important for pain research.
Purpose of the Study:
- To investigate the presence and characteristics of opioid binding sites in the rat spinal cord.
- To identify novel binding sites in the rat spinal cord using radioligands.
Main Methods:
- Radioligand binding assays were performed on rat spinal cord tissue.
- The binding profile of [3H]Bremazocine was characterized and compared to known opioid receptor subtypes.
Main Results:
- Rat spinal cord exhibited low levels of kappa-binding sites, comparable to rat brain tissue.
- [3H]Bremazocine labeled a distinct population of binding sites in the spinal cord.
- These [3H]Bremazocine-labeled sites did not exhibit mu, delta, or kappa opioid receptor specificity.
Conclusions:
- The rat spinal cord possesses a low density of kappa-opioid receptors.
- A novel, non-opioid (mu, delta, kappa) binding site is present in the rat spinal cord, labeled by [3H]Bremazocine.